MILEUTIS
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79367538
- Registration number
- 7636537
- Mark type
- Stylized text
- Filed
- 21 Mar 2023
- Published for opposition
- 17 Sept 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness
Owner
- MILEUTIS LTD, IL
- MILEUTIS LTD, IL
- MILEUTIS LTD, IL
Prosecution history
- 19 Jul 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Jul 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 02 Jul 2025 — FINAL DISPOSITION PROCESSED
- 07 Apr 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 11 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE